Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia 3Anemia, Refractory, with Excess of Blasts 3Thrombocytopenia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pathologic Complete Response 2Pancreatic Neoplasms 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Hodgkin Disease 2Congenital Abnormalities 2Breast Neoplasms 2Blast Crisis 2Uterine Cervical Neoplasms 1Thrombocytosis 1Prostatic Neoplasms 1Primary Myelofibrosis 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1

Interventions

abelacimab 1Tretinoin 1MAA868 1Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Tretinoin × Classical hematology × Clear all
NCT07586813 2026-05-14

N01-A-PICIT-GI

Peking University People's Hospital

Phase 2 Recruiting
220 enrolled
Classical hematologyGastrointestinal

Pathologic Complete Response, Digestive System Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Thrombocytopenia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡